Limits...
Platelet-Rich Plasma in Addition to Rehabilitation for Acute Hamstring Injuries in NFL Players: Clinical Effects and Time to Return to Play.

Rettig AC, Meyer S, Bhadra AK - Orthop J Sports Med (2013)

Bottom Line: The mean age was 23 years (range, 22-27 years) for the PRP group and 26 years (range, 22-28 years) for the non-PRP group (P = .42).The long head of biceps femoris was most commonly involved (4 in each group), with a single tear of the semimembranosus in each group.The median time to return to play was 20 days (range,16-30 days) in the PRP group and 17 days (range, 8-81 days) in the non-PRP group (P = .73).

View Article: PubMed Central - PubMed

Affiliation: Methodist Sports Medicine, Indianapolis, Indiana, USA.

ABSTRACT

Background: Platelet-rich plasma (PRP) injections have been proposed to hasten soft tissue healing. There is a lack of evidence in the current literature to support their efficacy in elite athletes.

Purpose: To investigate the effects of the addition of PRP to rehabilitation in the treatment of acute hamstring injuries in professional National Football League (NFL) players and to report the time to return to play.

Study design: Case control study.

Methods: Ten NFL players with similar hamstring injury patterns were retrospectively divided into 2 groups. The treatment group (PRP; n = 5) was injected with PRP and the control group (non-PRP; n = 5) was not injected; both groups completed a rehabilitation program. The PRP injections were administered under ultrasound guidance with precise localization of the injury site, within 24 to 48 hours of injury. Age, muscle involved, extent of injury, grading, and time to return to play were noted. Descriptive statistics and the exact Wilcoxon rank-sum test were used for data analysis.

Results: The mean age was 23 years (range, 22-27 years) for the PRP group and 26 years (range, 22-28 years) for the non-PRP group (P = .42). The median longitudinal extent of the injury was 14 cm (range, 9-18 cm) in the PRP group and 15 cm (range, 9-16 cm) in the non-PRP group (P = .77). The average transverse extent of the injury in the PRP and non-PRP groups was 4 cm (range, 1.6-6 cm) and 3.5 cm (range, 2-5 cm), respectively, and the respective average anteroposterior extent was 4 cm (range, 1.9-5 cm) and 2.9 cm (range, 1.5-4 cm). The long head of biceps femoris was most commonly involved (4 in each group), with a single tear of the semimembranosus in each group. The median injury classification was grade 2 in both groups. The median time to return to play was 20 days (range,16-30 days) in the PRP group and 17 days (range, 8-81 days) in the non-PRP group (P = .73).

Conclusion: There were no significant differences in recovery from hamstring injury between treatment with PRP and routine rehabilitation. A larger, randomized controlled trial is warranted.

No MeSH data available.


Related in: MedlinePlus

Time to return to play (days) and different position of the player in the field in (A) the treatment (PRP) group and (B) the control group. DB, defensive back; QB, quarterback; OL, offensive line; CB, cornerback; DL, defensive line; LB, linebacker; RB, running back; TE, tight end; PRP, platelet-rich plasma.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License 1 - License 2 - License 3
getmorefigures.php?uid=PMC4555507&req=5

fig1-2325967113494354: Time to return to play (days) and different position of the player in the field in (A) the treatment (PRP) group and (B) the control group. DB, defensive back; QB, quarterback; OL, offensive line; CB, cornerback; DL, defensive line; LB, linebacker; RB, running back; TE, tight end; PRP, platelet-rich plasma.

Mentions: The median time to return to play was 20 days in the treatment group and 17 days in the control group (Table 3). The difference in recovery time was not statistically significant (P = .73) (Figure 1). The details of the dimension of the hamstring injuries in both groups are summarized in Table 3. In the treatment group, the follow-up at 6 months after injury did not reveal scarring, persistent pain, injection-related complications, infection, or bruising. None of the patients from either group reported recurrence at follow-up.


Platelet-Rich Plasma in Addition to Rehabilitation for Acute Hamstring Injuries in NFL Players: Clinical Effects and Time to Return to Play.

Rettig AC, Meyer S, Bhadra AK - Orthop J Sports Med (2013)

Time to return to play (days) and different position of the player in the field in (A) the treatment (PRP) group and (B) the control group. DB, defensive back; QB, quarterback; OL, offensive line; CB, cornerback; DL, defensive line; LB, linebacker; RB, running back; TE, tight end; PRP, platelet-rich plasma.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License 1 - License 2 - License 3
Show All Figures
getmorefigures.php?uid=PMC4555507&req=5

fig1-2325967113494354: Time to return to play (days) and different position of the player in the field in (A) the treatment (PRP) group and (B) the control group. DB, defensive back; QB, quarterback; OL, offensive line; CB, cornerback; DL, defensive line; LB, linebacker; RB, running back; TE, tight end; PRP, platelet-rich plasma.
Mentions: The median time to return to play was 20 days in the treatment group and 17 days in the control group (Table 3). The difference in recovery time was not statistically significant (P = .73) (Figure 1). The details of the dimension of the hamstring injuries in both groups are summarized in Table 3. In the treatment group, the follow-up at 6 months after injury did not reveal scarring, persistent pain, injection-related complications, infection, or bruising. None of the patients from either group reported recurrence at follow-up.

Bottom Line: The mean age was 23 years (range, 22-27 years) for the PRP group and 26 years (range, 22-28 years) for the non-PRP group (P = .42).The long head of biceps femoris was most commonly involved (4 in each group), with a single tear of the semimembranosus in each group.The median time to return to play was 20 days (range,16-30 days) in the PRP group and 17 days (range, 8-81 days) in the non-PRP group (P = .73).

View Article: PubMed Central - PubMed

Affiliation: Methodist Sports Medicine, Indianapolis, Indiana, USA.

ABSTRACT

Background: Platelet-rich plasma (PRP) injections have been proposed to hasten soft tissue healing. There is a lack of evidence in the current literature to support their efficacy in elite athletes.

Purpose: To investigate the effects of the addition of PRP to rehabilitation in the treatment of acute hamstring injuries in professional National Football League (NFL) players and to report the time to return to play.

Study design: Case control study.

Methods: Ten NFL players with similar hamstring injury patterns were retrospectively divided into 2 groups. The treatment group (PRP; n = 5) was injected with PRP and the control group (non-PRP; n = 5) was not injected; both groups completed a rehabilitation program. The PRP injections were administered under ultrasound guidance with precise localization of the injury site, within 24 to 48 hours of injury. Age, muscle involved, extent of injury, grading, and time to return to play were noted. Descriptive statistics and the exact Wilcoxon rank-sum test were used for data analysis.

Results: The mean age was 23 years (range, 22-27 years) for the PRP group and 26 years (range, 22-28 years) for the non-PRP group (P = .42). The median longitudinal extent of the injury was 14 cm (range, 9-18 cm) in the PRP group and 15 cm (range, 9-16 cm) in the non-PRP group (P = .77). The average transverse extent of the injury in the PRP and non-PRP groups was 4 cm (range, 1.6-6 cm) and 3.5 cm (range, 2-5 cm), respectively, and the respective average anteroposterior extent was 4 cm (range, 1.9-5 cm) and 2.9 cm (range, 1.5-4 cm). The long head of biceps femoris was most commonly involved (4 in each group), with a single tear of the semimembranosus in each group. The median injury classification was grade 2 in both groups. The median time to return to play was 20 days (range,16-30 days) in the PRP group and 17 days (range, 8-81 days) in the non-PRP group (P = .73).

Conclusion: There were no significant differences in recovery from hamstring injury between treatment with PRP and routine rehabilitation. A larger, randomized controlled trial is warranted.

No MeSH data available.


Related in: MedlinePlus